Companies Related to "Neural Substrates in Nicotine Withdrawal" [Most Relevant Company Matches] RSS

21:32 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Neural Substrates in Nicotine Withdrawal" found in our extensive corporate database of over 50,000 company records.

Showing "Neural Substrates Nicotine Withdrawal" Companies 1–25 of 108


e-Nicotine Technology (eNT)

eNT is a healthcare company committed to reducing the harms associated with combustible tobacco products. eNT is developing the next generation of state-of-the-art electronic nicotine delivery products that quickly and dramatically reduce smoking urge while using 40-70% less nicotine than cigarettes or existing e-cigarettes. eNT’s products del...

Antidote Therapeutics, Inc.

Antidote Therapeutics, Inc. is a biotechnology company with a portfolio of first-in-class nicotine-blocking drugs to treat diseases caused or worsened by nicotine. In addition to Buerger’s Disease, ATI-1013 is also being investigated for Critical Limb Ischemia and nicotine addiction, and the company has other product candidates that neutralize or eli...

ABS Laboratories Ltd

ABS Laboratories Ltd is a contract research organisation formed from the Nicotine Laboratory at the Medical Toxicology Unit (formerly the National Poisons Unit). The Nicotine Laboratory was founded in January 1973 and is renowned for performing measurements of nicotine and cotinine to support smoking research and nicotine replacement therapies.Work produced by the laboratory has resulted in the pu...

Waismann Method

Performed in a hospital intensive care unit, the Waismann Method involves the administration of medications to reverse the physiological dependence on opiates while the symptoms of withdrawal are addressed. During the procedure, the patient experiences minimal conscious withdrawal, and will be able to return home within days. Seventy-five percent of the prescription drug dependent patients who ar...


ENDECE Neural is a private biotechnology company at the forefront of developing therapies to repair and potentially reverse damage caused by devastating neurological diseases such as multiple sclerosis (MS). A wholly owned subsidiary of ENDECE LLC, ENDECE Neural was founded in 2011 to focus on the development of what could be the first drug capable of indu...

Neural Analytics, Inc.

Neural Analytics was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, TBI and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their de...

Innovative Detox

Innovative Detox was created by four medical professionals to offer people addicted to alcohol or prescription painkillers a medically-sound alternative to traditional rehab. That can take a month or more to get their patients through withdrawal – followed by a lifetime of struggle to remain addiction-free by force of will – which produces a 75 percent ...

Smokefree Innotec, Inc.

Smokefree Innotec, Inc. is in the business of designing, developing, manufacturing and marketing hi-tech, nicotine and non-nicotine cigarette-like delivery devices which are completely smoke and vapor-free and tobacco-free. Smokefree Innotec’s products are designed to protect the non-smoker from second hand smoke and all its effects while providing th...

Renovo Neural Inc.

Renovo Neural Inc. ( is a privately held company in Cleveland, OH. The company is a specialized research organization providing services to biotech, pharmaceutical and research organizations. Renovo provides a new generation of ultrastructural analyses through its advanced 3D-electron microscopy infrastructure.


Biosubstrates have developed a totaly new concept, a designer partial with a designer culture WRF The substrates are sterilised dry so when they are re hydrated, what ever is in the water is drawn into the particles, the PH can be changed, nutrients, enzymes, bacteria what ever is needed can now be placed in the designer particles. substrates can be produced on site any where in the World.

Neural Analytics Inc.

Neural Analytics is creating products and services to measure, diagnose and track brain health with a current focus on Traumatic Brain Injury (TBI). NA combines leading edge data science with medical robotics to empower first responders and clinicians to accurately assess mild to severe TBI, including concussions. NA’s devices are portable, reliable...

Moss Incorporated

For almost a decade, Moss, Inc. has been exclusively dedicated to supplying Stable Liquid Substrates to the marketplace. Headquartered in Maryland with regional offices in California. Moss focuses strictly on "next generation" substrates which are liquid, stable, and non-toxic. Marketing is on a global basis for human and veterinary diagnostics and research. Applications include food, environment,...

Neural Intervention Technologies, Inc.

Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that result in hemorrhagic stroke.NIT is developing ALGEL™-I and -II, novel embolic materials, into minimally invasive treatments for cerebral arteriovenous malformations and aneurysms. In addition, NIT w...

Nabi Biopharmaceuticals

NABI Biopharmaceuticals are a biopharmaceutical company focused on the development of products that address unmet medical needs in the areas of nicotine addiction and infectious disease. We leverage our experience and knowledge in powering the human immune system to target serious medical conditions in these areas. Our lead products in development are NicVAX® [ Nicotine Conjugate Vaccine ], an in...

Cyberkinetics Neurotechnology

Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time neural signal decoding technology, and neural stimulation. The Company's mission is to commercialize products based upon these powerful platform technologies that restore function, including limb move...

Glycosynth Limited

Glycosynth is a specialist manufacturer of enzyme substrates accredited to ISO 9001:2000 standards. Our products find wide applications in clinical, food and environmental microbiology, plant molecular biology, and general diagnostics. We offer a range of 4-Methylumbelliferyl [4MU], Nitrophenyl, 7-Amido-4-methylcoumarin [AMC], Indolyl, Naphthyl and other substrates as well as a new range of patent...

Mitochon Pharmaceuticals, Inc.

Mitochon was founded in 2014 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to neurodegeneration, neuromuscular, and developmental diseases. Mitochon’s lead programs, MP101 and MP201, specifically harnesses the power of the mitochondria to provide broad neural protect...

US WorldMeds, LLC

US WorldMeds is a Kentucky-based specialty pharmaceutical company that develops, licenses and commercializes unique medical therapies that address unmet patient needs. US WorldMeds' products include novel treatments for malignant hyperthermia, cervical dystonia and symptoms of opiate withdrawal. For more information, please visit

Corning Incorporated

Corning Incorporated ( is the world leader in specialty glass and ceramics. Drawing on more than 150 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our pro...

Probably Relevant


In 2008, Filligent developed a revolutionary technology, called BioFriend(TM), which kills viruses and bacteria on contact. BioFriend's molecular technology can be applied to substrates such as rayon and cotton textile fiber. BioFriend(TM) captures pathogens by mimicking the sites on human cells to which they normally attach, then, destroys them by disrupting their surfaces (viruses) and cell ...

Mossman Associates Incorporated

Mossman Associates manufactures MycoDot™ a serological test for TB and NicCheckTM a urine dipstick test for measuring nicotine. Both tests are rapid, reliable and do not require instrumentation. We are also a source for biological reagents and raw materials as well as new and used equipment for purchase or lease.

OncoImmunin Incorporated

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued two U.S. patents on its proprietary design for protease inhibitors and fluorogenic substrates. The first PCT application has now entered into national phases in Japan and Europe and a second PCT was filed in 1998.OncoImmunin, Inc. has designed, synthesized, validated, and patented a new...

Fresh Start Private Management, Inc.

Fresh Start Private Management ( is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company. The company has licensed a treatment that delivers target therapeutic levels of Naltrexone that reduce patients' cravings for alcohol.

OncoImmunin, Inc

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued three U.S. patents and one Australian patent on its proprietary design for protease inhibitors and fluorogenic substrates. Multiple new applications as well CIP and PCT applications are under review.OncoImmunin, Inc. has designed, synthesized, validated, and patented a new class of prot...

Paradromics Inc.

Paradromics is developing high-volume bidirectional data streaming capabilities between brains and computers. Our neural interface technologies will initially be used to help physically disabled patients reconnect with the outside world -- with infinite possibilities beyond.

More From BioPortfolio on "Neural Substrates in Nicotine Withdrawal"

Quick Search


Corporate Database Quicklinks